- $1.59bn
- $1.88bn
- $1.44bn
- 55
- 91
- 88
- 92
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 428 | 932 | 1,326 | 1,519 | 1,437 |
Cost of Revenue | |||||
Gross Profit | 65.6 | 118 | 229 | 328 | 324 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 389 | 859 | 1,181 | 1,286 | 1,229 |
Operating Profit | 39.7 | 72.5 | 145 | 234 | 208 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 45.7 | 78.1 | 147 | 236 | 222 |
Provision for Income Taxes | |||||
Net Income After Taxes | 36.3 | 61.7 | 111 | 179 | 167 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 33 | 60.8 | 110 | 179 | 167 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 33 | 60.8 | 110 | 179 | 167 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.729 | 1.26 | 2.49 | 3.6 | 3.6 |